Bristlecone Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,137
Closed -$239K 271
2023
Q4
$239K Hold
1,137
0.02% 249
2023
Q3
$228K Sell
1,137
-32
-3% -$6.36K 0.03% 244
2023
Q2
$217K Buy
1,169
+32
+3% +$5.91K 0.02% 249
2023
Q1
$218K Buy
+1,137
New +$206K 0.02% 252
2022
Q3
Sell
-992
Closed -$203K 240
2022
Q2
$203K Buy
+992
New +$210K 0.03% 238

Other funds holding CME

Bristlecone Advisors's CME Position: Q1 2024 in Review

Bristlecone Advisors sold out of CME Group (CME) in Q1 2024, closing a stake of 1,137 shares — an estimated $239K sold.

Bristlecone Advisors first reported a position in CME in Q2 2022 and held it in 5 quarters. The position peaked at $239K in Q4 2023. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Bristlecone Advisors reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Bristlecone Advisors sold 1,137 CME Group shares in Q1 2024, an estimated $239K.
  • Bristlecone Advisors first reported a position in CME Group in Q2 2022 and held it in 5 quarters.
  • Bristlecone Advisors's CME Group position peaked at $239K in Q4 2023.
  • 1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Bristlecone Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.